How can we crack the code to healthy aging? Why is innovation a key catalyst for aging societies worldwide? What are the most pressing challenges in treating age-related, chronic diseases? And what are the most promising medical innovations to tackle these challenges?
Bayer presented a special LinkedIn Live session on the occasion of the UN’s International Day of Older Persons, in partnership with GCOA, to tackle these very questions. GCOA’s Susan Wile Schwarz moderated the discussion live with Mike Devoy, Chief Medical Officer, Bayer AG, Executive VP Medical Affairs & Pharmacovigilance for the Pharmaceuticals Division; Lothar Roessig, Clinical Development Group Head, Therapeutic Area Cardiology & Nephrology, Bayer’s Pharmaceuticals Division; and GCOA CEO Mike Hodin.
Watch a replay of the session here.